All surgeries were performed using a standard technique of sutureless 2.2 mm phacoemulsification. All incisions were made at the 12 o’clock position. Retrobulbar anaesthesia and mydriatic drops were instilled in all cases prior to the surgical procedure. After capsulorhexis creation with a cystotome under current irrigation through the cystotome needle, phacoemulsification and bimanual cortex peeling with capsule polishing, the IOLs were inserted into the capsular bag using the BLUEMIXS 180 injector (Carl Zeiss Meditec) through the main incisions. At the end of the surgery subconjunctival injection of dexamethasone and cefuroxime was administered. A postoperative therapy based on a combination of topical antibiotic and steroid was prescribed to be applied four times daily during two week.
Bluemixs 180
Manufactured by Zeiss
Sourced in Germany
The BLUEMIXS 180 is a compact and versatile benchtop microfluidic mixer designed for precise and efficient mixing of small liquid samples. It utilizes a proprietary microfluidic mixing technology to ensure rapid and homogeneous mixing of volumes ranging from microliters to milliliters.
Automatically generated - may contain errors
Lab products found in correlation
7 protocols using bluemixs 180
1
Sutureless Phacoemulsification with IOL Implantation
2
Sutureless Phacoemulsification with IOL Implantation
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
All surgeries were performed by the same experienced surgeon (RM) using a standard technique of sutureless 2.2-mm phacoemulsification. Before the surgical procedure, topical anesthesia and mydriatic drops were instilled in all cases. A temporal 2.2-mm clear corneal incision and a 5.5-mm circular capsulorrhexis were performed, and after phacoemulsification the IOL was inserted into the capsular bag using a specific injector (BLUEMIXS 180, Carl Zeiss Meditec). A postoperative topical therapy based on a combination of antibiotics and steroids was prescribed to be applied four times daily for 1 week. Nonsteroidal anti-inflammatory drops were applied 3 times just before surgery, and postoperatively 3 times per day for 4 weeks.
3
Phacoemulsification with Sutureless Microcoaxial Technique
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Experienced surgeons performed all surgeries using a standard, sutureless, micro-coaxial 2.2-mm phacoemulsification technique. All incisions were made at the steep axis of the cornea. Topical anesthesia and mydriatic drops were instilled prior to the surgical procedure in all cases. After capsulorrhexis creation and phacoemulsification, the IOLs were inserted into the capsular bag through the main incision using the BLUEMIXS 180 injector (Carl Zeiss Meditec). A postoperative topical therapy of combined antibiotic and steroid (tobramycin 0.3%, dexamethasone 0,1%; Tobradex, Alcon, Fort Worth, TX, USA) was prescribed to be applied four times daily for 1 week.
4
Cataract Surgery with AT LISA tri 839MP IOL
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Surgeries were performed by three experienced surgeons JF, JA, AK. Standard hydrodissection and cataract extraction by phacoemulsification was performed in all cases. The AT LISA tri 839MP IOL was subsequently implanted in the capsular bag using a qualified injector (BLUEMIXS 180, Carl Zeiss Meditec, Jena, Germany) in combination with a viscoelastic device. At the end of the surgery, any residual ophthalmic viscoelastic device was thoroughly removed by irrigation/aspiration, and side ports and main incision were sealed by hydration. Postoperative treatment and medication were given according to the routine procedure in each centre.
5
Sutureless Microcoaxial Phacoemulsification Technique
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Topical anaesthesia and mydriatic drops were instilled in all cases prior to the surgical procedure. All surgeries were performed by the same experienced surgeon (DB) using a standard technique of sutureless microcoaxial 2.2-mm phacoemulsification. All incisions were made at the steep axis of the cornea. After capsulorhexis creation and phacoemulsification, the IOLs were inserted into the capsular bag using the BLUEMIXS 180 injector (Carl Zeiss Meditec, Jena, Germany) through the main incision.
Postoperatively, all patients received the same treatment: a combination of an antibiotic, steroid, and nonsteroidal anti-inflammatory agent.
Postoperatively, all patients received the same treatment: a combination of an antibiotic, steroid, and nonsteroidal anti-inflammatory agent.
6
Cataract Surgery with IOL Implantation
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Surgeons could use their own preferred technique, but this was similar across centres and the three IOL groups. Topical, loco-regional or general anaesthesia was used followed by continuous curvilinear capsulorhexis. In the majority of cases, the IOL was inserted into the capsular bag using the recommended injector (BLUEMIXS 180, Carl Zeiss Meditec for the AT LARA 829MP and CT ASPHINA 409MP and UNFOLDER, Platinum 1 series, J&J for TECNIS Symfony).
All surgeries were performed using standard self-sealing clear corneal incision, capsulorhexis and conventional phacoemulsification. The recommended incision size was ≤ 2.4 mm for the TECNIS Symfony and ≤ 2.2 mm for AT LARA 829MP and CT ASPHINA 409MP. Emmetropia was targeted in all cases. At the end of the surgery, any residual ophthalmic viscoelastic device was thoroughly removed from the posterior chamber by irrigation, and side ports and main incision were sealed by hydration. Post-operative treatment and medication were given according to the routine procedure in each centre.
All surgeries were performed using standard self-sealing clear corneal incision, capsulorhexis and conventional phacoemulsification. The recommended incision size was ≤ 2.4 mm for the TECNIS Symfony and ≤ 2.2 mm for AT LARA 829MP and CT ASPHINA 409MP. Emmetropia was targeted in all cases. At the end of the surgery, any residual ophthalmic viscoelastic device was thoroughly removed from the posterior chamber by irrigation, and side ports and main incision were sealed by hydration. Post-operative treatment and medication were given according to the routine procedure in each centre.
7
Bilateral Trifocal IOL Implantation
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The same experienced surgeon (J.F.A.) performed all surgeries. The technique included topical anesthesia, a 2.2-mm clear corneal microincision, capsulorhexis creation, and phacoemulsification (Infiniti Vision System; Alcon Laboratories, Fort Worth, TX). Phacoemulsification was followed by irrigation and aspiration of the cortex and implantation of the AT LISA tri 839MP trifocal IOL in the capsular bag using the Bluemixs 180 injector (Carl Zeiss Meditec). Postoperative topical therapy including anti-inflammatory and antibiotic medications was used for 4 weeks. The time between the 2 surgeries was 7 days.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!